このページの翻訳は実験的なもので、現在開発中です。お待ちしております

Physiomics 将来の成長

Future 基準チェック /06

現在、 Physiomicsの成長と収益を予測するのに十分なアナリストの調査がありません。

主要情報

n/a

収益成長率

n/a

EPS成長率

Life Sciences 収益成長	25.8%
収益成長率	n/a
将来の株主資本利益率	n/a
アナリストカバレッジ	Low
最終更新日	27 Sep 2024

今後の成長に関する最新情報

Recent updates

It's Unlikely That Shareholders Will Increase Physiomics Plc's (LON:PYC) Compensation By Much This Year

Nov 15

Here's Why We Think Physiomics Plc's (LON:PYC) CEO Compensation Looks Fair

Nov 17

Here's Why Shareholders Will Not Be Complaining About Physiomics Plc's (LON:PYC) CEO Pay Packet

Nov 16

What Can We Conclude About Physiomics' (LON:PYC) CEO Pay?

Feb 08

業績と収益の成長予測

AIM:PYC - アナリストの将来予測と過去の財務データ ( )GBP Millions
日付	収益	収益	フリー・キャッシュフロー	営業活動によるキャッシュ	平均アナリスト数
6/30/2025	1	-1	N/A	-1	1
6/30/2024	1	-1	-1	-1	N/A
3/31/2024	1	-1	-1	0	N/A
12/31/2023	1	0	0	0	N/A
9/30/2023	1	0	0	0	N/A
6/30/2023	1	0	0	0	N/A
3/31/2023	1	0	0	0	N/A
12/31/2022	1	0	0	0	N/A
9/30/2022	1	0	0	0	N/A
6/30/2022	1	0	0	0	N/A
3/31/2022	1	0	0	0	N/A
12/31/2021	1	0	0	0	N/A
9/30/2021	1	0	0	0	N/A
6/30/2021	1	0	0	0	N/A
3/31/2021	1	0	0	0	N/A
12/31/2020	1	0	0	0	N/A
9/30/2020	1	0	0	0	N/A
6/30/2020	1	0	0	0	N/A
3/31/2020	1	0	0	0	N/A
12/31/2019	1	0	0	0	N/A
9/30/2019	1	0	0	0	N/A
6/30/2019	1	0	0	0	N/A
3/31/2019	1	0	0	0	N/A
12/31/2018	1	0	0	0	N/A
9/30/2018	1	0	0	0	N/A
6/30/2018	1	0	0	0	N/A
3/31/2018	0	0	N/A	0	N/A
12/31/2017	0	0	N/A	0	N/A
9/30/2017	0	0	N/A	0	N/A
6/30/2017	0	0	N/A	0	N/A
3/31/2017	0	0	N/A	0	N/A
12/31/2016	0	0	N/A	0	N/A
9/30/2016	0	0	N/A	0	N/A
6/30/2016	0	0	N/A	0	N/A
3/31/2016	0	0	N/A	0	N/A
12/31/2015	0	0	N/A	0	N/A
9/30/2015	0	0	N/A	0	N/A
6/30/2015	0	0	N/A	0	N/A
3/31/2015	0	0	N/A	0	N/A
12/31/2014	0	0	N/A	0	N/A
9/30/2014	0	0	N/A	0	N/A
6/30/2014	0	0	N/A	0	N/A
3/31/2014	0	0	N/A	0	N/A
12/31/2013	0	0	N/A	-1	N/A

アナリストによる今後の成長予測

収入対貯蓄率: PYCの予測収益成長が貯蓄率 ( 1.9% ) を上回っているかどうかを判断するにはデータが不十分です。

収益対市場: PYCの収益がUK市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です

高成長収益: PYCの収益が今後 3 年間で大幅に増加すると予想されるかどうかを判断するにはデータが不十分です。

収益対市場: PYCの収益がUK市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。

高い収益成長: PYCの収益が年間20%よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。

一株当たり利益成長率予想

将来の株主資本利益率

将来のROE: PYCの自己資本利益率が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です

Physiomics 将来の成長

Future 基準チェック /06

主要情報

今後の成長に関する最新情報

Physiomics Plc Increases Revenue Expectation for the Year 2025

Physiomics plc Announces Earnings Guidance for the Year Ending June 30, 2021

Recent updates

Full year 2024 earnings: Revenues miss analyst expectations

New minor risk - Financial data availability

New major risk - Shareholder dilution

Dr. Christophe Chassagnole Step Down as Director and as Chief Scientific Officer of Physiomics plc

Physiomics Plc Increases Revenue Expectation for the Year 2025

First half 2024 earnings released: UK£0.002 loss per share (vs UK£0.002 loss in 1H 2023)

Physiomics Plc to Report First Half, 2024 Results on Mar 07, 2024

New minor risk - Shareholder dilution

Less than half of directors are independent

Physiomics plc Announces Chief Executive Officer Changes

It's Unlikely That Shareholders Will Increase Physiomics Plc's (LON:PYC) Compensation By Much This Year

Physiomics Plc, Annual General Meeting, Nov 21, 2023

Physiomics Plc Appoints Dr Venkata Putcha, as Head of Biostatistics

Full year 2023 earnings: EPS in line with expectations, revenues disappoint

New minor risk - Financial data availability

New minor risk - Financial data availability

Physiomics plc Appoints Dr. Peter Sargent as Chief Operating Officer

New minor risk - Shareholder dilution

First half 2023 earnings released: UK£0.002 loss per share (vs UK£0.001 loss in 1H 2022)

Physiomics plc Announces Change of Job Title of Dr. Christophe Chassagnole from Chief Operating Officer to Chief Scientific Officer

Physiomics Plc Announces Successful Completion of its PARTNER Study

Here's Why We Think Physiomics Plc's (LON:PYC) CEO Compensation Looks Fair

Full year 2022 earnings: EPS and revenues exceed analyst expectations

Physiomics Plc, Annual General Meeting, Nov 22, 2022

Third quarter 2022 earnings released: UK£0.001 loss per share (vs UK£0.001 loss in 3Q 2021)

Physiomics Plc to Report Fiscal Year 2022 Results on Sep 29, 2022

Physiomics Plc Appoints Shalabh Kumar as Independent Non-Executive Director

Less than half of directors are independent

Physiomics plc Announces Board Changes, Effective April 1, 2022

First half 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Physiomics Plc to Report First Half, 2022 Results on Mar 07, 2022

Physiomics plc Announces Board Changes

Here's Why Shareholders Will Not Be Complaining About Physiomics Plc's (LON:PYC) CEO Pay Packet

Full year 2021 earnings released: UK£0.002 loss per share (vs UK£0.001 loss in FY 2020)

Physiomics plc Announces Earnings Guidance for the Year Ending June 30, 2021

First half 2021 earnings released: UK£0.001 loss per share (vs UK£0.001 loss in 1H 2020)

What Can We Conclude About Physiomics' (LON:PYC) CEO Pay?

TRHC’s DoseMeRx Partners with Physiomics to Provide Precision Dosing for Oncology Medications

Physiomics Plc Announces Approval of NIHR-funded PARTNER Study

Full year earnings released - UK£0.00087 loss per share

Annual earnings released: Earnings beat expectations, revenue disappoints

Physiomics plc Receives Award from Bicycle Therapeutics plc and Merck KGaA to Further Contracts of Undisclosed Value for Projects

Full year earnings released - UK£0.00087 loss per share

Physiomics Plc to Report Fiscal Year 2020 Results on Sep 30, 2020

業績と収益の成長予測

アナリストによる今後の成長予測

一株当たり利益成長率予想

将来の株主資本利益率

成長企業の発掘